Biomedical Warming and Thawing Devices Market COVID-19 Impact Analysis, Trends, Business Growth & Forecast 2027

On this note, the Biomedical Warming and Thawing Devices Market size is estimated to surpass USD 308.1 million by 2027, as per the latest study by Global Market Insights Inc.


Anand Joshi

4 months ago | 3 min read

Rising cases of accidental injuries and trauma cases will boost biomedical warming and thawing devices market share. A rise in the number of blood transfusion centers and blood banks is being witnessed on the back of robust policies promoting blood donation.

A notable trend for the development of precision surgery, regenerative medicine, immunotherapy, personalized therapeutics and immunotherapy will drive the demand for thawing devices. Stakeholders are expected to focus on research and development activities to boost the use of cryopreserved samples. In terms of value, global biomedical warming and thawing devices market size will surpass USD 308 million by 2027.

To access a sample copy or view the market report in detail along with the table of contents, please click the link below:

Of late, the demand for automatic warming and thawing devices has surged given that they do away with a water-bath-based and conventional manual approach. These devices are well-positioned to underpin rapid warming rate and streamline temperature read-out of the thawing process. End-users are investing in automated thawing devices in non-cellular therapeutic materials, such as plasma samples.

Leading companies are exhibiting traction for ovum/embryo samples on the heels of soaring infertility rates and the adoption of in vitro fertilization (IVF) and embryo transfer. According to the CDC, around 6% of married women in the U.S. in the age group between 15- and 44-years grapple with infertility concerns, while approximately 12% of women face complications carrying a pregnancy to term.

The U.S. National Embryo Donation Academy suggested that there were around 1 million embryos in storage in 2021. Some of the dynamics such as the high success rate of embryo cryopreservation, identical IVF pregnancy rates and the use of vitrification will further the penetration of the sample. The market share from ovum/embryo segment is forecast to expand at a healthy CAGR of around 9.3% through 2027.

Stakeholders are touted to garner significant gain from the pharmaceutical sector following the rise in research spending and studies. Developments in diagnostic technologies will streamline the use of cell-based functional assays in the discovery process and advancements in drugs. Leading companies have upped investment in products that provide clinical benefits.

To illustrate, Lonza, in 2021, rolled out tailored cryopreserved Leukopaks which are sought for long-term storage in research laboratories. It is also said to provide quick access to cells for flexibility and better convenience in the workflow. The biomedical warming and thawing devices market value from the pharmaceutical segment is likely to surpass USD 35 million by 2027.

The Latin America market is poised to expand at an impressive CAGR of 8.4% through 2027 owing to increasing cases of accidental injuries in Brazil. According to the WHO, over 90% of road traffic deaths are witnessed in low-and middle-income countries. Brazil is touted to be a happy hunting ground following the rise in road accidents and the implementation of robust policies. Demand for blood transfusion for managing patient’s health will trigger the industry growth. The Brazil biomedical warming and thawing devices market could grow strong at around 8.4% CAGR through 2027.

Both legacy players and new entrants are expected to focus on both organic and inorganic strategies as they look to gain a stronghold across the landscape. In doing so, strategic alliance, mergers & acquisitions and collaboration will be pronounced in the ensuing period.  The industry includes participants such as Brook Life Sciences, Helmer Scientific, Sarstedt AG & Co. KG, Barkey, Boekel Scientific, Cytiva, BioLife Solutions and Cardinal Health, among others. For instance, MEQU, in April 2021, announced the launch of an in-hospital solution for its blood and IV fluid warming device M Warmer System.

The trend for automation in life science facilities and the expansion of key players will augur well for the biomedical warming and thawing devices industry outlook.

Partial Table of Contents (ToC) of the report:

Chapter 4   Biomedical Warming and Thawing Devices Market, By Product

4.1    Key segment trends

4.2    Manual

4.2.1    Market size, by region, 2016 – 2027 (USD Million)

4.3    Automatic

4.3.1    Market size, by region, 2016 – 2027 (USD Million)

Chapter 5   Biomedical Warming and Thawing Devices Market, By Sample

5.1    Key segment trends

5.2    Blood products

5.2.1    Market size, by region, 2016 - 2027 (USD Million)

5.3    Ovum/embryo

5.3.1    Market size, by region, 2016 - 2027 (USD Million)

5.4    Semen

5.4.1    Market size, by region, 2016 - 2027 (USD Million)

5.5    Others

5.5.1    Market size, by region, 2016 - 2027 (USD Million)

Browse complete table of content of this report @

About Global Market Insights

Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Aashit Tiwari

Corporate Sales, USA

Global Market Insights Inc.

Toll Free: +1-888-689-0688

USA: +1-302-846-7766

Europe: +44-742-759-8484

APAC: +65-3129-7718



Created by

Anand Joshi







Related Articles